Medicine Description gemzar 200mg
Gemzar 200mg i.v. vial is a sterile injectable medication manufactured by Lilly that contains the active ingredient Gemcitabine. Gemcitabine works by interfering with the growth and reproduction of cancer cells, thereby slowing down or stopping their spread in the body.
Indications and Uses of Gemzar 200mg i.v. vial
- Treatment of pancreatic cancer.
- Management of non-small cell lung cancer (NSCLC).
- Treatment of breast cancer.
- Use in bladder cancer cases.
- Therapy for ovarian cancer.
How to Use Gemzar 200mg i.v. vial
- Administer intravenously under the supervision of a healthcare professional.
- Ensure the solution is clear and free from particles before use.
- Use aseptic techniques during administration.
- Monitor the patient for any adverse reactions during and after infusion.
Contraindications of Gemzar 200mg i.v. vial
- Hypersensitivity to Gemcitabine or any of its components.
- Severe bone marrow suppression.
- Pregnancy and breastfeeding.
- Active infections.
- Severe liver impairment.
Drug Interactions
- May interact with other chemotherapy agents.
- Potential interaction with antiviral medications.
- Caution when used with drugs that affect liver enzymes.
Side Effects of Gemzar 200mg i.v. vial
- Nausea and vomiting.
- Fatigue and weakness.
- Low blood cell counts leading to anemia.
- Increased risk of infections.
- Rash or skin reactions.
Storage and Handling
Store in a cool, dry place away from light. Keep out of reach of children.
Warnings and Precautions
Patients should be cautious when driving due to possible fatigue. Pregnant or breastfeeding women should avoid using this medication unless advised by a doctor. Use caution in elderly patients or those with pre-existing health conditions. Seek medical attention if unusual symptoms occur.